Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

PGC-1α research offers new hope for weight loss by boosting metabolic efficiency and providing accessible management ...

The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.

Biotechnology companies are developing novel obesity medicines to compete with blockbuster weight-loss drugs.

Aiming to live ‘as neighbors, not roommates,’ two New Yorkers devised a plan to combine their budgets and become the co-owners of a two-family or three-family house. The year ended with ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...